Jean-luc L. Harousseau

Nantes St Herblain
Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025.

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025.

Journal: European journal of haematology

Published: November 01, 2025

Toward a cure for multiple myeloma within a decade.

Toward a cure for multiple myeloma within a decade.

Journal: Blood cancer journal

Published: October 17, 2025

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Journal: Blood cancer journal

Published: July 07, 2025

Precision medicine for multiple myeloma: The case for translocation (11;14).

Precision medicine for multiple myeloma: The case for translocation (11;14).

Journal: Cancer treatment reviews

Published: June 09, 2024

A roadmap towards improving outcomes in multiple myeloma.

A roadmap towards improving outcomes in multiple myeloma.

Journal: Blood cancer journal

Published: June 04, 2024

Potential future direction of measurable residual disease evaluation in multiple myeloma.

Potential future direction of measurable residual disease evaluation in multiple myeloma.

Journal: Blood

Published: February 27, 2023

Sequencing anti-BCMA therapies in myeloma.

Sequencing anti-BCMA therapies in myeloma.

Journal: Blood

Published: January 19, 2023

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH).

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH).

Journal: Clinical hematology international

Published: January 15, 2023

Beyond medicines' barriers: exploring the true cost of multiple myeloma.

Beyond medicines' barriers: exploring the true cost of multiple myeloma.

Journal: Journal of medical economics

Published: November 18, 2022

Systematic literature review of health economic models developed for multiple myeloma to support future analyses.

Systematic literature review of health economic models developed for multiple myeloma to support future analyses.

Journal: Journal of medical economics

Published: November 08, 2022

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.

Journal: Blood cancer journal

Published: January 06, 2022

Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids.

Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 02, 2021

Showing 1-12 of 51

Last Updated: 09/26/2026